(via NewsDirect)
Barder highlights the opportunity by the
He also expresses optimism about obtaining regulatory approval for OTC sales in the US by the end of June.
Contact Details
+44 20 7989 0813
uk@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source